Oligonucleotide therapeutics--novel cardiovascular targets.
Isner
J M
JM
D000818:Animals; D042846:CDC2-CDC28 Kinases; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D051357:Cyclin-Dependent Kinase 2; D018844:Cyclin-Dependent Kinases / Q000235:genetics; D006801:Humans; D008081:Liposomes; D017346:Protein Serine-Threonine Kinases / Q000235:genetics; D016372:RNA, Antisense / Q000627:therapeutic use*; D018108:Respirovirus / Q000235:genetics
D008081:Liposomes; D016372:RNA, Antisense; D017346:Protein Serine-Threonine Kinases; D042846:CDC2-CDC28 Kinases; C495894:CDK2 protein, human; D051357:Cyclin-Dependent Kinase 2; D018844:Cyclin-Dependent Kinases